戻る Agenda
Session 2: The IND in Detail - Modules 1, 2, and 5
Session Chair(s)
Drusilla Scott, PHD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
- IND Item 1: Form FDA 1571
- IND Item 2: Table of Contents
- IND Item 3: Introductory Statement
- IND Item 4: General Investigation Plan
- IND Item 5: Investigator’s Brochure
- IND Item 6: Protocols